Screener
Lexicon Pharmaceuticals LXRX Interest Expense
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InterestPaidNet.
The source filing: Lexicon Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001062822-26-000117
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Repayment of debt borrowings | (59,261) | (45,000) |
| Payment of financing fees | (2,274) | — |
| Net cash provided by (used in) financing activities | 88,244 | (45,572) |
| Net decrease in cash, cash equivalents and restricted cash | (22,402) | (16,292) |
| Cash, cash equivalents, and restricted cash at beginning of period | 63,326 | 66,656 |
| Cash, cash equivalents, and restricted cash at end of period | $40,924 | $50,364 |
| Supplemental disclosure of cash flow information: | ||
| Cash paid for interest | $2,606 | $4,888 |
Item 1. Financial Statements
FAQ
- What is Lexicon Pharmaceuticals's interest expense?
- Lexicon Pharmaceuticals (LXRX) reported interest expense of $1.13M in Q2 2026.
- How has Lexicon Pharmaceuticals's interest expense changed year-over-year?
- Lexicon Pharmaceuticals's interest expense decreased by 41.2% year-over-year, from $1.92M to $1.13M.
- What is the long-term trend for Lexicon Pharmaceuticals's interest expense?
- Over 4 years (2021 to 2025), Lexicon Pharmaceuticals's interest expense has grown at a 79.5% compound annual growth rate (CAGR), from $802K to $8.33M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.
Ask your AI about Lexicon Pharmaceuticals's interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude